HealthEquity, Inc. $HQY Shares Sold by Danske Bank A S

Key Points

• Danske Bank A S cut its position in HealthEquity by 94.7% in Q4, selling 12,409 shares and retaining just 700 shares worth about $64,000, per the SEC filing.
• HealthEquity beat expectations for the quarter with $0.95 EPS vs. $0.90 expected and $334.59M in revenue (vs. $332.48M), with revenue up 7.3% year-over-year.
• Analysts have a consensus rating of "Moderate Buy" with an average price target of $111.79 (targets range roughly $100–$128); the breakdown includes 1 Strong Buy, 12 Buys, 1 Hold and 1 Sell.

Danske Bank A S cut its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 94.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 700 shares of the company's stock after selling 12,409 shares during the quarter. Danske Bank A S's holdings in HealthEquity were worth $64,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HQY. AQR Capital Management LLC raised its holdings in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company's stock worth $116,016,000 after purchasing an additional 661,795 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in HealthEquity by 35.7% during the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company's stock worth $162,688,000 after purchasing an additional 451,450 shares during the last quarter. Woodline Partners LP acquired a new position in HealthEquity during the third quarter worth $26,193,000. Vanguard Group Inc. raised its holdings in HealthEquity by 2.9% during the third quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company's stock worth $828,883,000 after purchasing an additional 243,549 shares during the last quarter. Finally, Marshall Wace LLP raised its holdings in HealthEquity by 460.2% during the third quarter. Marshall Wace LLP now owns 293,182 shares of the company's stock worth $27,785,000 after purchasing an additional 240,847 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. UBS Group set a $110.00 price target on HealthEquity in a report on Tuesday, February 17th. Jefferies Financial Group set a $108.00 price target on HealthEquity in a report on Thursday, February 19th. Royal Bank Of Canada cut their price target on HealthEquity from $110.00 to $100.00 and set an "outperform" rating for the company in a report on Wednesday, March 18th. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $120.00 to $128.00 and gave the stock a "buy" rating in a report on Thursday, March 19th. Finally, Barclays cut their price target on HealthEquity from $118.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, HealthEquity has an average rating of "Moderate Buy" and an average target price of $111.79.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $83.99 on Friday. The company has a market cap of $7.10 billion, a P/E ratio of 34.14, a P/E/G ratio of 1.51 and a beta of 0.19. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $116.65. The business has a fifty day simple moving average of $81.30 and a 200-day simple moving average of $87.78.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million during the quarter, compared to the consensus estimate of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The company's quarterly revenue was up 7.3% on a year-over-year basis. Equities research analysts forecast that HealthEquity, Inc. will post 3.84 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.